Product NDC: | 0409-1985 |
Proprietary Name: | Lorazepam |
Non Proprietary Name: | LORAZEPAM |
Active Ingredient(s): | 2 mg/mL & nbsp; LORAZEPAM |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-1985 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074243 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110526 |
Package NDC: | 0409-1985-05 |
Package Description: | 1 BLISTER PACK in 1 BOX (0409-1985-05) > 10 SYRINGE in 1 BLISTER PACK > 1 mL in 1 SYRINGE |
NDC Code | 0409-1985-05 |
Proprietary Name | Lorazepam |
Package Description | 1 BLISTER PACK in 1 BOX (0409-1985-05) > 10 SYRINGE in 1 BLISTER PACK > 1 mL in 1 SYRINGE |
Product NDC | 0409-1985 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | LORAZEPAM |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20110526 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | LORAZEPAM |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |